Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus
- 1 December 2010
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 16 (6) , 445-456
Abstract
Despite widespread use of antiretroviral therapies to control replication of the human immunodeficiency virus (HIV), dysfunctions of cognition that are collectively termed HIV-associated...Keywords
This publication has 41 references indexed in Scilit:
- Deregulation of sphingolipid metabolism in Alzheimer's diseaseNeurobiology of Aging, 2010
- Order of lipid phases in model and plasma membranesProceedings of the National Academy of Sciences, 2009
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainNeurobiology of Aging, 2009
- Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapyJournal of NeuroVirology, 2009
- White matter tract injury and cognitive impairment in human immunodeficiency virus–infected individualsJournal of NeuroVirology, 2009
- A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosisBrain, 2008
- Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Cortical Atrophy and White Matter Hyperintensities in HIV: The Hawaii Aging with HIV Cohort StudyJournal of Stroke and Cerebrovascular Diseases, 2008
- Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapyJournal of NeuroVirology, 2008
- LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificityBiochemical Journal, 2006